Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
nimotuzumab
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
nimotuzumab
Unique ID
C501466
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C501466
Entry Term(s)
Theraloc
theracim-HR3
Pharm Action
Antineoplastic Agents, Immunological
Registry Numbers
6NS400BXKH
CAS Type 1 Name
Immunoglobulin G1, anti-(humanized mouse monoclonal hR3 beta1 chain anti-human epidermal growth factor receptor), disulfide with humanized mouse monoclonal hR3 kappa-chain, dimer
Previous Indexing
*ANTIBODIES, MONOCLONAL (2005-2011)
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
218
Note
a humanized monoclonal antibody that binds to the epidermal growth factor receptor
Source
Curr Opin Mol Ther 2005 Apr;7(2):182-91
Date of Entry
2005/06/23
Revision Date
2019/10/31
Expand All
Collapse All
nimotuzumab
Preferred
Concept UI
M0486221
Registry Numbers
6NS400BXKH
Terms
nimotuzumab
Preferred Term
Term UI
T644080
Date
06/23/2005
LexicalTag
NON
ThesaurusID
Theraloc
Narrower
Concept UI
M0555119
Terms
Theraloc
Preferred Term
Term UI
T786311
Date
02/28/2011
LexicalTag
TRD
ThesaurusID
NLM (2011)
theracim-HR3
Narrower
Concept UI
M000654695
Terms
theracim-HR3
Preferred Term
Term UI
T000966244
Date
08/22/2019
LexicalTag
NON
ThesaurusID
NLM (2020)
page delivered in 0.006s